• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Deals

Grand Cayman on the Cayman Islands
Biotech

Lepu supplies 2 T-cell engagers to NewCo in $857M deal

Newcomer Excalipoint, incorporated in the Cayman Islands, has also secured a $41 million series A financing.
Darren Incorvaia Aug 1, 2025 11:11am
Sanofi

Sanofi pens $395M China pact for Arrowhead metabolic med

Aug 1, 2025 7:21am
Question

AbbVie in talks over $1B Gilgamesh buyout: report

Jul 31, 2025 7:48am
liver

Madrigal pens $2B deal for CSPC's GLP-1, eyes Rezdiffra pairing

Jul 30, 2025 7:35am
Three blocks displaying from left to right a person a handshake and another person

Kissei pays Viridian $70M to challenge Amgen for Japanese market

Jul 30, 2025 4:50am
liver

Bausch Health bags phase 3-ready liver prospect in $63M buyout

Jul 29, 2025 9:35am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings